INTRODUCTION: Oesophagogastric cancer surgery is increasingly being performed in only centralised units. The aim of the study was to examine surgical outcomes and service delivery within a specialist unit. PATIENTS AND METHODS: The case notes of all patients undergoing attempted oesophagogastrectomy between January 2000 and May 2003 were identified from a prospective consultant database. RESULTS: A total of 187 patients (median age, 63 years; range, 29-83 years; M:F ratio, 3.9:1) underwent attempted oesophago-gastrectomy. Of these, 91% were seen within 2 weeks of referral and treatment was instituted after a mean of 31 days (range, 1-109 days). More patients underwent surgery (63%) than neoadjuvant therapy (56%) within 1 month of referral. The main indication for surgery was invasive malignancy in 166 patients (89%). The 30-day mortality was 0.5% (1 death) and in-hospital mortality was 1.1% (2 deaths). The median length of hospital stay was 14 days (range, 7-69 days). Significant postoperative morbidity included: pulmonary complications (36%), cardiovascular complications (16%), wound infection (13%) and clinically significant anastomotic leaks (7%). Of the study group, 28 patients (15%) were admitted to ICU with a median stay of 10 days (range, 1-44 days); this accounted for 0.9% of ICU bed availability. Twelve patients (6.4%) were returned to theatre, most commonly for bleeding. The 1-year survival rates were 78%. During 2002-2003, national waiting list targets for both hernia repair and cholecystectomy were achieved. CONCLUSIONS: Despite recent increases in workload, high volume specialist units can deliver an efficient and timely service with both good treatment outcomes and minimal impact upon elective surgical waiting lists and ICU provision.
INTRODUCTION:Oesophagogastric cancer surgery is increasingly being performed in only centralised units. The aim of the study was to examine surgical outcomes and service delivery within a specialist unit. PATIENTS AND METHODS: The case notes of all patients undergoing attempted oesophagogastrectomy between January 2000 and May 2003 were identified from a prospective consultant database. RESULTS: A total of 187 patients (median age, 63 years; range, 29-83 years; M:F ratio, 3.9:1) underwent attempted oesophago-gastrectomy. Of these, 91% were seen within 2 weeks of referral and treatment was instituted after a mean of 31 days (range, 1-109 days). More patients underwent surgery (63%) than neoadjuvant therapy (56%) within 1 month of referral. The main indication for surgery was invasive malignancy in 166 patients (89%). The 30-day mortality was 0.5% (1 death) and in-hospital mortality was 1.1% (2 deaths). The median length of hospital stay was 14 days (range, 7-69 days). Significant postoperative morbidity included: pulmonary complications (36%), cardiovascular complications (16%), wound infection (13%) and clinically significant anastomotic leaks (7%). Of the study group, 28 patients (15%) were admitted to ICU with a median stay of 10 days (range, 1-44 days); this accounted for 0.9% of ICU bed availability. Twelve patients (6.4%) were returned to theatre, most commonly for bleeding. The 1-year survival rates were 78%. During 2002-2003, national waiting list targets for both hernia repair and cholecystectomy were achieved. CONCLUSIONS: Despite recent increases in workload, high volume specialist units can deliver an efficient and timely service with both good treatment outcomes and minimal impact upon elective surgical waiting lists and ICU provision.
Authors: S G Swisher; L Deford; K W Merriman; G L Walsh; R Smythe; A Vaporicyan; J A Ajani; T Brown; R Komaki; J A Roth; J B Putnam Journal: J Thorac Cardiovasc Surg Date: 2000-06 Impact factor: 5.209
Authors: J A Ajani; J A Roth; B Ryan; M McMurtrey; T A Rich; D E Jackson; J L Abbruzzese; B Levin; L DeCaro; C Mountain Journal: J Clin Oncol Date: 1990-07 Impact factor: 44.544
Authors: Fady Yanni; Pritam Singh; Nilanjana Tewari; Simon L Parsons; James A Catton; John Duffy; Neil T Welch; Ravinder S Vohra Journal: World J Surg Date: 2019-10 Impact factor: 3.352
Authors: Ahmed H Hamouda; Matthew J Forshaw; Kostas Tsigritis; Greg E Jones; Aliya S Noorani; Ash Rohatgi; Abraham J Botha Journal: Surg Endosc Date: 2010-04 Impact factor: 4.584
Authors: Geoffrey Paul Kohn; Joseph Anton Galanko; Michael Owen Meyers; Richard Harry Feins; Timothy Michael Farrell Journal: J Gastrointest Surg Date: 2009-09-16 Impact factor: 3.452
Authors: Christopher P Twine; S Ashley Roberts; Jonathan D Barry; Huw Oliphant; Matthew A Morgan; Guy R J Blackshaw; Wyn G Lewis Journal: Eur Radiol Date: 2008-10-29 Impact factor: 5.315
Authors: Karyn B Stitzenberg; Elin R Sigurdson; Brian L Egleston; Russell B Starkey; Neal J Meropol Journal: J Clin Oncol Date: 2009-08-31 Impact factor: 44.544
Authors: L Vallejo-Torres; M Melnychuk; C Vindrola-Padros; M Aitchison; C S Clarke; N J Fulop; J Hines; C Levermore; S B Maddineni; C Perry; K Pritchard-Jones; A I G Ramsay; D C Shackley; S Morris Journal: Br J Surg Date: 2018-03-07 Impact factor: 6.939